ADCs take center stage as promising cancer treatments

At the European Society for Medical Oncology meeting, ADCs were the belle of the cancer research ball.

October 27, 2023 Check out STAT+

Sponsored By

Andrew Joseph/STAT STAT+ | With an old approach but new energy, ADCs take center stage as promising cancer treatments ADCs are designed to deliver chemotherapy directly to tumors, possibly one day replacing the blunt-force toxic therapies. By Andrew Joseph STAT+ | Oncologists more likely to provide low-value care after receiving pharma money, study finds The findings from a new study raise questions about the extent to which industry influence may have led to patient harm. By Ed Silverman Cancer disparities persisted even among clinical trial participants, study finds Black and Hispanic patients had worse cancer outcomes despite access to high-quality treatment, pointing to other challenges. By Angus Chen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser